Navigation Links
QuickSite LV Lead

ProductsQuickSite LV Lead
Company St. Jude Medical, Inc.
Item QuickSite LV Lead
Features 
  • S-shaped distal lead body - Enhances acute and chronic stability
  • OTW or stylet approach compatibility - Gives the option of using either approach during the procedure to ensure a successful implant
  • Back-loading or front-loading capability - Gives the implanting physician the option to use whichever approach is most appropriate
  • Composite lead body and conductors - Provides pushability and torqueability to improve handling. Soft distal portion allows tracking along a wire. Improves overall maneuverability.
  • Fast-Pass coating - Allows multiple leads to slide against one another easily. Designed to potentially reduce dislodgment of one lead while manipulating another lead.
  • Steerable tip Designed to improve maneuverability and navigation into tortuous veins
  • Grooved, circumferential tip electrode - Enhances chronic stability and thresholds
  • Steroid elution - Reduces tissue inflammation and scarring, and lowers acute and chronic thresholds
  • Titanium nitride fractal coating - Lowers polarization and increases stimulation efficiency
  • Radiopaque suture sleeve - Enables suture sleeve visibility on fluoroscopy without blocking visibility of the underlying coils
  • Traffic Light stylet configuration Offers easy identification of stylet stiffness
Description The QuickSite model 1056K LV lead is designed to ensure chronic stability and to promote shorter procedure times, delivering a complete package of quality, performance, and reliability.

The QuickSite LV lead is a highly innovative, technologically advanced left ventricular lead, including such features as S-shaped fixation, over-the-wire or stylet-driven compatibility, and front and back loading capability. The steroid-eluting lead is implantable with a 7 Fr introducer.

Info St. Jude Medical, Inc.
Customer Service: (800) 328-9634
Web site: http://www.sjm.com

Related medicine products :

1. T2™ Humeral Nailing System
2. Ascent Primary Knee System - Ascent/Maxim CoCr I-Beam Tibial Tray
3. Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
4. Advance Uni-Comparental Knee Components - Uni Metal-backed Tibial Component
5. Advance Uni-Compartmental Knee Components - Uni Metal-backed Tibial Component
6. BioPro Uni-compartmental Knee System - Uni-compartmental Tibial Tray
7. Genesis II Tibial Instrumentation
8. MIS Tibial Stylus
9. MIS Tibial Saw Guide
10. Tibial Alignment Guide Assembly
11. MIS Proximal Tibial Alignment Guide
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure 2Health News:Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 3Health News:The Dignity Memorial(R) Network Honors Four Individuals Who Gave the Gift of Life Through Organ and Tissue Donation 2Health News:The Dignity Memorial(R) Network Honors Four Individuals Who Gave the Gift of Life Through Organ and Tissue Donation 3
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 1OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 2OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 3Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 1Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 2Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 1Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 2